Antiparasitical chemotherapy in Chagas’ disease cardiomyopathy: current evidence

I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo

(2011) Jadelson Pinheiro de Andrade et al.   Arquivos Brasileiros de Cardiologia

Current status of Chagas disease chemotherapy

(2011) Paulo MM Guedes et al.   Expert Review of Anti-Infective Therapy

Nitric oxide donor trans-[RuCl([15]aneN4)NO]2+ as a possible therapeutic approach for Chagas' disease

(2010) Paulo MM Guedes et al.   BRITISH JOURNAL OF PHARMACOLOGY

Advances in Chagas disease drug development: 2009–2010

(2010) Frederick S Buckner et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease

(2010) Bianca P. Olivieri et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Chagas disease

(2010) Anis Rassi et al.   LANCET

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

(2010) Marta de Lana et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease

(2010) J. Altcheh et al.   PEDIATRICS

Current and developing therapeutic agents in the treatment of Chagas disease

(2010) Werner Apt   Drug Design Development and Therapy

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi

(2010) Yen Ting Chen et al.   PLoS Neglected Tropical Diseases

Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery

(2009) Juan M. Burgos et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

(2009) Josep M Escribà et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up

(2009) CD Fernandes et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI

(2009) B Zingales et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

The role of parasite persistence in pathogenesis of Chagas heart disease

(2009) F. R. S. GUTIERREZ et al.   PARASITE IMMUNOLOGY

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

(2008) Jose Antonio Marin-Neto et al.   AMERICAN HEART JOURNAL

Antiparasitic compounds that target DNA

(2008) W. David Wilson et al.   BIOCHIMIE

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions

(2008) Ivo Santana Caldas et al.   PARASITOLOGY RESEARCH